跳至主要内容
临床试验/ACTRN12609000727246
ACTRN12609000727246已完成1 期

In infants with a family history of allergic disease, is daily application of a ceramide dominant emollient for six weeks safe?

Murdoch Childrens Research Institute0 个研究点目标入组 10 人开始时间: 2009年8月24日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
1 Weeks 至 3 Weeks(—)
性别
All

入选标准

  • Either mother and/or father has a self reported history of:
  • - asthma and/or
  • - eczema/atopic dermatitis and/or
  • - hayfever/allergic rhinitis and/or
  • - food allergy

排除标准

  • - A parent who has a known hypersensitivity to any of the ingredients of EpiCeram.
  • - Multiple births (twins, triplets etc.)
  • - Premature infants (<36 weeks)
  • - Infants with major birth or early life medical complications that require admission into a special care nursery.

研究者

相似试验

Prevention of Eczema By a Barrier Lipid Equilibrium... | 临床试验